Key findings from ESMO Congress 2023 showcase groundbreaking advances in cancer treatment, including potential new first-line treatments for urothelial cancer, advancements in perioperative treatment for non-small cell lung cancer, and progress in the treatment of chemorefractory KRAS G12C-mutated metastatic colorectal cancer.
English (US) ·